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RESUMO 
 
SILVA, R.O.S. AVALIAÇÃO DE INDICADORES DE ESTRUTURA EM UM 
SERVIÇO DE REVISÃO DA FARMACOTERAPIA. Trabalho de Monografia do 
curso de Farmácia da Universidade Federal de Sergipe, 2014. 
 
Este estudo avalia indicadores de estrutura empregados na implantação do Serviço 
de Revisão da Farmacoterapia. Foi realizada uma pesquisa de desenvolvimento 
metodológico de março de 2012 a março de 2013, no Serviço de Revisão da 
Farmacoterapia do ambulatório-escola, de um Hospital Universitário no Nordeste do 
Brasil, em duas etapas consecutivas. A primeira etapa consistiu de uma busca na 
literatura sobre indicadores de estrutura para Serviços de Revisão da 
Farmacoterapia. Na segunda etapa foi feita a avaliação por meio dos indicadores 
reunidos na etapa anterior. Reunimos 28 indicadores de estrutura necessários para 
avaliar outros Serviços de Revisão da Farmacoterapia que foram divididos em cinco 
categorias: instalações físicas, recursos humanos, recursos materiais, 
documentação e financiamento. O Serviço de Revisão da Farmacoterapia analisado 
atendeu a maioria dos indicadores sugeridos pela literatura.  
 
Palavras-chave: revisão da farmacoterapia; avaliação de qualidade de serviços; 
indicadores de estrutura 
 
 
 
 
 
 
 
 
 
ABSTRACT 
 
SILVA, R.O.S.  EVALUATION OF A STRUCTURAL INDICATORS IN A 
MEDICATION REVIEW SERVICE. Monograph Pharmacy Course at the Federal 
University of Sergipe, 2014. 
 
This study evaluates structure indicators used in the implantation of the Medication 
Review Service. Developmental research methodological was carried out from 
March 2012 to March 2013, at the Medication Review Service of the school-based 
outpatient clinic of the University Hospital in Northeastern Brazil, in two consecutive 
steps. The first step consisted on a searching in the literature about structure 
indicators for Medication Review Service. On the second step was done the 
evaluation through the indicators gathered in the previous step. We gathered 28 
structure indicators needed to assess other Medication Review Services that were 
divided into five categories: physical areas, human resources, material resources, 
documentation and funding. The Medication Review Service analyzed attended 
most indicators suggested by the literature.  
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INTRODUÇÃO 
 
A crescente morbimortalidade relacionada aos medicamentos é considerada 
um problema de saúde pública relevante em vários países do mundo, visto que o 
uso simultâneo de vários medicamentos tem se tornado uma ferramenta comum na 
prática clínica (Galato et al., 2010; Manasse Jr. e Thompson, 2005). Em 
consequência, os custos com a morbimortalidade relacionada à farmacoterapia nos 
Estados Unidos foram estimados em US$ 300 bilhões de dólares (Center for 
Disease Control and Prevention, 2014; Rottenkolberet al., 2011). No mesmo país, os 
gastos provocados por problemas relacionados aos medicamentos (PRMs) foram 
duas vezes maiores que os gastos com os próprios medicamentos (Baker, 2004; 
Ernst e Grizzle, 2001).  
Diante do exposto, a Organização Mundial de Saúde (OMS) (2002) 
estabeleceu como seu grande desafio para a década de 2010 a promoção e melhora 
na racionalidade do uso de medicamentos. Assim, OMS tem destacado que o papel 
do farmacêutico pode ser determinante para a prevenção de erros de medicação e 
promoção do uso racional de medicamentos, no que concerne às orientações dos 
pacientes nos diversos cenários de prática como hospitais, farmácias comunitárias e 
ambulatórios (World Health Organization, 1994; World Health Organization, 1998). 
Nessa perspectiva, estudos demonstram que o aumento das consultas e 
outros serviços farmacêuticos em ambientes ambulatoriais proporcionam a 
oportunidade para otimizar o estado de saúde dos pacientes, como o seguimento 
farmacoterapêutico (Hirsch et al., 2014; Molino et al., 2014; Wei et al., 2014) e a 
Revisão da Farmacoterapia (Goh et al., 2014; Lenander et al., 2014). Este último 
serviço, foi definido inicialmente como a avaliação crítica e estruturada dos 
medicamentos do paciente com o objetivo de alcançar um comum acordo sobre sua 
farmacoterapia, otimizando o tratamento, diminuindo os problemas relacionados a 
medicamentos (PRMs) e os gastos dos sistemas de saúde (Shaw et al., 2002).  
Na prática Clínica, a Revisão da Farmacoterapia vem trazendo diversos 
resultados clínicos, econômicos e humanísticos (López et al., 2012; Patterson et al., 
2011; Riley, 2013). Em uma revisão sistemática com 54 estudos, Hatah et al. (2014) 
concluíram que a Revisão da Farmacoterapia teve impacto significamente positivo 
sobre os resultados dos pacientes, como redução dos níveis pressóricos, níveis de 
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LDL (lipoproteína de baixa densidade), taxas de hospitalizações e PRMs, além de 
aumentar a adesão a farmacoterapia. Embora este serviço seja desenvolvido em 
vários países (Patterson et al., 2011; Leikola, 2012; Salgado et al., 2012) e, em 
alguns destes, com respaldo dos sistemas de saúde (Pharmaceutical Services 
Negotiating Committee, 2013; Pharmaceutical Society of Australia, 2011), as 
publicações sobre serviços farmacêuticos que se autodenominem como um serviço 
de Revisão da Farmacoterapia na América Latina são incipientes. 
Neste cenário faz mais de uma década que a avaliação da qualidade dos 
serviços de cuidados vem ganhando força na maioria dos sistemas de saúde (Morris 
et al., 2002). Isso é explicado principalmente pelos prejuízos gerados pela 
morbimortalidade relacionada a medicamentos e a nova conjuntura dos sistemas de 
saúde em fornecer incentivos financeiros aos prestadores de cuidados (McBane et 
al., 2011). Assim, a nova tendência das agências de saúde é exigir dos prestadores 
de cuidados o mais alto grau de qualidade dos serviços de saúde ao menor custo 
possível (Mainz, 2003). 
 Um dos primeiros autores a estudar a avaliação da qualidade dos serviços de 
saúde foi Avedis Donabedian (1966). Segundo o mesmo para a qualidade em 
saúde, pode ser avaliada sob tríade estrutura, processo e resultado (Modelo SPO). 
A estrutura corresponde aos recursos físicos, humanos, materiais, instrumentos 
normativos e administrativos utilizados, assim como as fontes de financiamento. O 
processo, por sua vez, diz respeito às interações e procedimentos envolvendo 
profissionais de saúde e pacientes, enquanto que os resultados (outcomes) se 
referem à alteração no estado de saúde atribuível à intervenção em saúde 
(Donabedian, 1966, 1978). 
Embora desde a década de 1970 sejam utilizados modelos para a avaliação 
da qualidade de serviços farmacêuticos (Mikael et al., 1975). No Brasil, estudos com 
foco no planejamento, monitorização e avaliação de serviços clínicos farmacêuticos, 
como a revisão da farmacoterapia são escassos. Portanto, é necessário que mais 
investigações sejam realizadas a fim de implantar, avaliar e difundir serviços clínicos 
que garantam a qualidade do cuidado e a segurança do paciente. 
Diante do exposto, este estudo fez parte da Dissertação de Mestrado em 
Ciências Farmacêuticas da Universidade Federal de Sergipe de Genival Araújo dos 
Santos Júnior, intitulado: “Indicadores de estrutura e de processo em Serviços de 
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Revisão da Farmacoterapia”. O estudo será apresentado em forma de artigo com o 
título de: “Evaluation of a structural indicators in a Medication Review Service”. 
Este estudo será submetido à Health & Place – an International Journal, que possui 
qualis A2 e fator de impacto 2,435. 
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INTRODUCTION 
 
In last three decades, clinical services established with pharmacists’ 
knowledge and skills have encouraged the training of health care professionals in the 
selection and monitoring of pharmacotherapy in practice scenarios, such as 
hospitals, community pharmacies, and ambulatory care clinics (Roberts et al., 2008; 
World Health Organization, 1994; World Health Organization, 1998). Among clinical 
pharmaceutical practices that focus on patients and help improve clinical, humanistic, 
and economic outcomes, Medication Review stands out (Doucette et al., 2009; El-
Ibiary et al., 2008; Hatah et al., 2014; Murray et al., 2007; Planas et al., 2009). 
Initially, Medication Review was defined as the careful analysis of medications 
used by patients to optimize their treatment, decrease drug related problems 
(DRPs),and decrease health system costs (Hatah et al., 2014; Shaw et al., 
2002).Recently, Leikola (2012) confirmed that the main benefit of Medication Review 
is the improvement of outpatient therapeutic regimens. 
In the United States, the expansion of these services started ten years ago and 
led patients and health plans to require the assessment of outpatient pharmaceutical 
care, such as Medication Review, focusing on cost-benefit ratio (Mainz, 2003). It is 
important to emphasize that quality assessment guarantees health care and health 
services management. Therefore, it is necessary to measure the efforts of 
institutions, the quality of health services provided, and their utility and social 
relevance (Adami, Maranhão, 1995; Carayon et al., 2014). 
In this scenario, the model “structure-process-outcome” has been used to 
identify and associate processes developed by pharmacists and patient outcomes 
(Farris, Kirking, 1993; Nau, 2009). According to Donabedian (1966, 1978), structural 
indicators correspond to physical, human, and material resources regulatory and 
administrative instruments used, as well as funding sources. Process indicators, in 
turn, refer to interactions and procedures that involve health care professionals and 
patients, while the outcomes are measured by changes in health status that occur as 
a result of health care intervention.  
Although these concepts are widely used, healthcare professionals, including 
pharmacists, have not assimilated the integrated concept of quality improvement in 
the clinical context (Bruchet, Loewen, 2011; Carayon et al., 2014). Consequently, 
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McBane et al. (2011) report the existence of few measures to assess the quality of 
different care services provided by pharmacists, including Medication Review. 
In Brazil, for instance, there is no framework of standardized procedures, 
processes, or workflows to assess the quality of these services. Moreover, in this 
country, studies to address the quality of pharmaceutical services, such as 
Medication Review, still need to be performed. Therefore, further investigations 
would be required to optimize the quality of review services and health outcomes. 
Considering this, the aim of this study was to assess structural indicators for the 
implementation of the Medication Review service in a school-based ambulatory care 
clinic of the University Hospital in Northeastern Brazil. 
METHODS 
 
Developmental research methodological was carried out from March 2012 to 
March 2013, at the Medication Review Service of the school-based outpatient clinic 
of the University Hospital in Northeastern Brazil. The evaluation of pharmaceutical 
services was based on the model proposed by Donabedian (1988), focused on 
structure. Due to the lack of instruments to assess structural indicators for Medication 
Review, this study was divided into two consecutive phases. 
The first phase consisted in finding and defining structural indicators of 
pharmaceutical services that could be properly adapted to Medication Review in 
outpatient clinics. Therefore, two international guidelines were selected:1) 
“Guidelines for pharmacists providing Home Medicines Review (HMR) services” 
developed by the Pharmaceutical Society of Australia (2011); and 2) “Minimum 
Standard for Pharmaceutical Services in Ambulatory Care” proposed by the 
American Society of Health-System Pharmacists (ASHP) (1999). Moreover, six 
national research studies (Aguiar et al., 2013; Correr et al., 2004; França-Filho et 
al.,2008; Lyra Jr., 2005; Rios et al., 2013; Silva, 2003) served as theoretical 
references to define the indicators that would then be analyzed.  
The two international guidelines aimed to assess pharmaceutical services. On 
the other hand, the selected Brazilian studies addressed structural indicators for 
community or outpatient pharmacies with or without clinical pharmacy services. 
Hence, two pharmacists-investigators (G.A.S.J. and C.C.S.) selected, compiled, and 
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adapted structural indicators for this study, according to the theoretical framework 
proposed by Donabedian (1980). The degree of agreement between the two 
pharmacists was calculated using the Kappa index, which may vary from 0 to 1. The 
closer to 1 the index is, the higher is the agreement between the evaluators. For 
different responses, a third pharmacist (T.C.M.) was consulted to break the tie. 
In the second phase of the study, Medication Review Service structural 
indicators were evaluated based on the structural indicators previously identified. It is 
important to emphasize that evaluations of the studies analyzed are self-evaluations. 
Therefore, to reduce possible biases and to provide an external validation of the 
results, each criterion was assessed by a pharmacist-investigator (G.A.S.J.) and a 
pharmacist-auditor (D.T.S.) external to the Medication Review service of the 
outpatient clinic analyzed. For each item, the responses of pharmacists-evaluators 
were grouped into three possible categories: yes (for items included in the service), 
no (for items not included) and not applicable (when the criterion did not suit local 
realities). The degree of agreement of these responses was also calculated by the 
Kappa index. All data collected were entered twice into an Excel spreadsheet and a 
descriptive statistical analysis was carried out. 
This study was approved by the Research Ethics Committee of the University 
Hospital, Federal University of Sergipe (Brazil), under registration CAAE number 
11735412.5.0000.5546. The pharmacists, physicians, Medical and Pharmacy 
students signed The Informed Consent (TCLE). 
 
RESULTS 
 
Structural indicators for the Medication Review service 
 
In this study, only structural indicators to assess the Medication Review service 
were considered, although both guidelines also contained items for processes, which 
still need to be analyzed. Therefore, among the 77 items recommended by the ASHP 
(1999), only 14 refer to structural indicators. A clinical pharmacy service must satisfy 
the criteria highlighted in the guideline to reach the minimum standard. These are 
divided into four main categories: (I) leadership and management practice; (II) 
15 
 
pharmacotherapy and pharmaceutical care; (III) control and distribution of medicines; 
(IV) installations, equipment, and other resources. The guideline also points out that 
although these requirements may vary from place to place depending on the patients’ 
needs, the criteria are strongly associated with the outcomes of the services provided 
to the patients and neglecting them may compromise service quality.  
Similarly, in “Guidelines for pharmacists providing Home Medicines Review 
(HMR) services” (Pharmaceutical Society of Australia, 2011), only two items assess 
the structure of the service and were applied in this study. This guideline also covers 
the fundamental rules governing most types of Medication Review services existing 
in that country. Moreover, it also recommends that pharmacists familiarize 
themselves with other professional guidelines. Therefore, Medication Review practice 
must satisfy the 30 criteria recommended by the Pharmaceutical Society of Australia 
(2011), which are described in the guideline. 
The degree of agreement between the two evaluators referring to all structural 
indicators was moderate (k=0.522). However, after consensus on divergent items 
was reached, the index was excellent (k=0.894). The structural indicators that were 
defined are described in Table 1. 
 
Table 1. Structural indicators for clinical pharmacy services  
Structural indicators Reference 
PHYSICAL AREAS 
Private area: private area to evaluate and guide 
the patient, to enable the assessment of his/her 
knowledge, understanding, and adherence to 
the prescribed pharmacotherapy and follow-up 
care plans. The space should accommodate the 
pharmacist, the patient, and when appropriate, 
family members or caregivers 
 
(Aguiar et al., 2013; American 
Society of Health-System 
Pharmacists, 1999; Correr et 
al., 2004; França-Filho et al., 
2008; Lyra Jr., 2005) 
Administrative area: area for administrative 
activities, meetings, and training 
(American Society of Health-
System Pharmacists, 1999) 
Furniture (wardrobe, desk, and chair): furniture Aguiar et al., 2013; Lyra Jr., 
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suitable for providing care with patient seating 
and cabinets to store materials and 
documentation. 
2005; Rios et al., 2013) 
Internet: internet access available to the 
pharmacist. 
(Aguiar et al., 2013; Correr et 
al., 2004; Lyra Jr., 2005) 
HUMAN RESOURCES 
Trained pharmacists: pharmacists with the 
necessary knowledge and skills to conduct 
Medication Review 
(Aguiar et al., 2013; American 
Society of Health-System 
Pharmacists, 1999; Correr et 
al., 2004; França-Filho et al., 
2008; Lyra Jr., 2005) 
Trained staff: auxiliary staff trained to fulfill their 
responsibilities and work with pharmacists in 
Medication Review services 
(Aguiar et al., 2013;  American 
Society of Health-System 
Pharmacists, 1999;Correr et 
al., 2004; França-Filho et al., 
2008; Lyra Jr., 2005) 
Years to graduate in Pharmacy: time (in years) 
for the pharmacist to graduate. 
(Aguiar et al., 2013; Correr et 
al., 2004; França-Filho et al., 
2008; Lyra Jr., 2005) 
Years of experience in clinical pharmaceutical 
services: time (in years) the pharmacist has 
worked in services such as clinical pharmacy, 
pharmaceutical care, Medication Review, or 
follow-up. 
(Aguiar et al., 2013; Correr et 
al., 2004; Lyra Jr., 2005) 
Highest degree of the pharmacist (PharmD, 
MSc, PhD, or post-doctorate): previous 
participation of the pharmacist in graduate 
courses. 
(Aguiar et al., 2013; Correr et 
al., 2004; Lyra Jr., 2005) 
 
Level of knowledge of foreign languages: the 
pharmacist should have at least basic 
knowledge of other foreign languages. 
(Aguiar et al., 2013; Correr et 
al., 2004; França-Filho et al., 
2008; Lyra Jr., 2005) 
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Pharmacist coordinator/Technical manager: the 
service should have a legally qualified and 
professionally competent pharmacist 
coordinator. The pharmacist technician in 
charge should know or have management 
experience or ambulatory care practice.  
(American Society of Health-
System Pharmacists, 1999; 
Silva, 2003) 
Computer knowledge: experience in computer 
tools and internet resources used in the 
Medication Review service. 
(França-Filho et al., 2008; Lyra 
Jr., 2005) 
Pharmacist license: all pharmacists must have a 
license provided by their professional 
association to practice their occupation. 
(American Society of Health-
System Pharmacists, 1999; 
Pharmaceutical Society of 
Australia, 2011; Silva, 2003) 
Working conditions of the staff: working 
conditions and remuneration in accordance with 
labor laws. 
(Silva, 2003) 
Certified technicians: all technicians must have 
the certification to practice their occupation in 
pharmaceutical services. 
(American Society of Health-
System Pharmacists, 1999) 
 
MATERIAL RESOURCES 
Computer equipment (hardware): equipment, 
such as computers and printers, should be 
available to be used whenever necessary in the 
Medication Review service.  
(Correr et al., 2004; França-
Filho et al., 2008; Lyra Jr., 
2005; Rios et al., 2013) 
Information system: computerized system to 
archive the patients’ information, drug therapy 
profile, and care plans. 
(American Society of Health-
System Pharmacists, 1999) 
Medical devices: availability of medical devices 
that can be used in Medication Review, such as 
sphygmomanometer, stethoscope, 
thermometer, glucometer, and others. 
(Aguiar et al., 2013; Rios et 
al., 2013; Silva, 2003) 
Consumable materials: the office supplies used, 
such as paper, pen, among others, should be 
(Lyra Jr., 2005; Rios et al., 
2013; Silva, 2003) 
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available in a sufficient amount to meet the 
requirement of the service. 
Available sources of information (primary, 
secondary, and tertiary): should include 
scientific and professional journals and latest 
editions of textbooks. 
(Aguiar et al., 2013;American 
Society of Health-System 
Pharmacists, 1999; Correr et 
al., 2004; França-Filho et al., 
2008; Lyra Jr., 2005; Rios et 
al., 2013;Silva, 2003) 
Drug therapy form: the service should keep an 
updated form with the medicines approved by 
the medical staff. 
(American Society of Health-
System Pharmacists, 1999) 
DOCUMENTATION 
Mission: the service should have a written 
mission that reflects patient care and the 
responsibilities of the service.  
(American Society of Health-
System Pharmacists, 1999) 
Standards and technical procedures: a manual 
with all rules and procedures that govern 
outpatient pharmacy care (administrative, 
operational, and clinical) should be available 
and regularly updated. 
(American Society of Health-
System Pharmacists, 1999; 
Silva, 2003) 
Laws and regulations: the pharmacist should 
maintain written or computerized documentation 
regarding law and recommendations 
compliance (local, state, and federal) applied to 
pharmaceutical services in outpatient clinics. 
(American Society of Health-
System Pharmacists, 1999; 
Silva, 2003) 
Record of patients’ clinical information: patients’ 
clinical information should be recorded and 
stored in a secure location with restricted 
access. 
(Silva, 2003) 
Work schedules: work schedules, procedures, 
and staff assignments should exist to ensure 
safety, pharmaceutical, and patient care. 
(American Society of Health-
System Pharmacists, 1999) 
Description of roles and functions: (American Society of Health-
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responsibilities and competencies of 
pharmacists and staff should be clearly defined 
and written. 
System Pharmacists, 1999) 
FUNDING 
Funding for the service (Aguiar et al.,  2013) 
 
Evaluation of the Medication Review service of a school-based outpatient clinic 
 
The evaluation of structural indicators of the Medication Review service was 
carried out in the second phase of the study, for which the degree of agreement 
between pharmacist-investigator and pharmacist-auditor, who was external to the 
service, was excellent (k=0.889). 
Regarding the evaluation of physical facilities, the outpatient clinic had an air-
conditioned private room of approximately 12m2 for pharmacy care that was not 
exclusive to the Medication Review service. The furniture of the room was similar to 
other outpatient clinics and included a table, chairs, a stretcher, and a cabinet. The 
material resources used were purchased with the pharmacist’s own funds and funds 
from other research projects. Therefore, sources of primary, secondary, and tertiary 
information were rendered available to pharmacists, physicians, patients, Medical 
students, and Pharmacy students. Importantly, despite the lack of computers with 
internet access, the service had a tablet with internet access that allowed quick 
searches of evidence-based medicine content. Consumables were acquired over the 
period of care provision and it was not necessary to purchase medical devices 
(sphygmomanometer, stethoscope, glucometer, thermometer, etc.).  
With regard to human resources, although not from the University Hospital 
under study, four pharmacists (one coordinator and three caregivers) and eight 
Pharmacy students (four trainees, two undergraduate students, and two volunteer 
students) formed the Medication Review service. All twelve had a workload of 20 
hours per week and most of them were women (58.33%; n=7). 
The average age of the pharmacists was 30.75 ± 8.73 years and 50% were 
men (n=2). With regard to training, two pharmacists were MSc students, one was a 
PhD student, and one was a post-doc; the average time for graduation was 8 ± 8.04 
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years and the average time of direct patient care experience was 5.5 ± 4.36 years. All 
pharmacists had advanced knowledge of English. 
The average age of the Pharmacy students was 22.25 ± 1.28 years and the 
majority were women (62.5%; n=5) and attended the eighth semester of the 
Pharmacy course. Half of these students had intermediate English levels, three 
spoke basic English, and only one was fluent. Most students (75%; n=6) had never 
cared for patients in clinical care-focused services. Therefore, before starting service 
attendance, all students participated in a training course organized and promoted by 
pharmacists, which consisted of 20 hours of theoretical training (four hours of service 
simulation, four hours of searching sources of information, four hours of legal aspects 
on medical prescription, four hours of documentation, and four hours of 
pharmaceutical diagnosis) and 32 hours of practical training (direct practice 
observation and supervised service, which were monitored by the pharmacists in 
charge).The entire staff (pharmacists and Pharmacy students) had advanced 
computer knowledge. 
As computers were not available, the documents were manually prepared, 
using forms adapted by the authors of the study (Cipolle et al., 2012). Regarding 
service documentation, care flowcharts (standards and technical procedures) were 
printed out and rendered available to all the staff members.  
As for financial resources and since three pharmacists and two undergraduate 
students were participating in research projects, they were funded by local and 
national agencies. Moreover, it is important to notice that Medication Review was 
paid according to procedures listed in the table of the Brazilian Unified Health System 
(SUS) and according to the consultation category of senior level professionals for 
specialized care. However, the resources obtained were curiously not used to directly 
support the service. 
 
 
DISCUSSION 
 
Implantation of quality clinical pharmacy services, initially, requires the 
development of research on structures to delineate the profile of existing conditions 
that translate into changes necessary for their viability (Correr et al., 2004; França-
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Filho et al., 2008 ; Lyra Jr., 2005; Silva, 2003). As proposed by Donabedian (1980), 
structural indicators should be initially used to evaluate and implement health 
services as these are essential for subsequent phases, including processes and 
outcomes.  
In this study, we observed that several international indicators found were 
similar to national indicators. Therefore, the international guidelines selected to 
evaluate structural indicators of Medication Review service complemented indicators 
of selected national studies. This similarity can be explained by a new global 
tendency in pharmacy wherein the pharmacists’ activities are not only focused on 
medicines but also on providing care (Nkansah et al., 2010). Therefore, indicators 
could be used to evaluate these services. 
The adaptation of several indicators assessed in this study to meet the local 
reality is recommended in the literature (American Society of Health-System 
Pharmacists, 1999). For instance, the U.S. guideline “Minimum Standard for 
Pharmaceutical Services in Ambulatory Care” recommends that pharmacists 
evaluate and adapt these rules to meet the requirements of each practice that is 
being carried out (American Society of Health-System Pharmacists, 1999). Moreover, 
the literature shows that protocols and guidelines developed by professional societies 
should be used as parameters for quality improvement (Woolf et al., 1999). 
Therefore, the adoption of international standards and national indicators may have 
been crucial for structuring the service. According to Donabedian (1980), it is 
important to assess structural measures, because they influence processes and 
results.  
As for human resources, the qualification of the pharmacists and their prior 
experience in patient care were important for the implementation of this service. In 
countries such as Australia and Finland, in addition to experience, pharmacists 
undergo accreditation processes and participate in periodic updates while conducting 
Medication Review services (American Society of Health-System Pharmacists, 1999; 
Leikola, 2012). Although no accreditation processes have been established so far in 
Brazil, Smith (2009) emphasizes that the clinical experience of pharmacists may 
positively influence patients’ health outcomes. This allows patients to take care of 
themselves and contributes, together with other health professionals, to ensure the 
appropriate, cost-effective, safe, and convenient use of medication. Moreover, the 
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implementation of indicators in Brazil may contribute to the development of future 
accreditation processes in these clinical pharmacy services. 
With regard to human resources, the literature emphasizes the importance of 
training programs and effective supervision, which aims to increase the knowledge 
and practice of pharmacists and students, thus improving the care provided to the 
community (Minh et al., 2013). In this study, the fact that all pharmacists were 
involved in teaching and research may have facilitated the training process of 
Pharmacy students who were interested in developing clinical services, which 
favored the implementation of the service and the formation of a practice 
environment. 
As recommended by the ASHP, in Medication Review services pharmacists and 
Pharmacy students must go through a selection process, and theoretical and 
practical training to improve the knowledge and skills required developing patient 
care activities (American Society of Health-System Pharmacists, 1999). In this study, 
the selected students were trained by pharmacists of the service and invited 
according to relevant topics for the Medication Review. It is important to emphasize 
that due to insufficient knowledge and skills offered by the curricula of Pharmacy 
students, as established by Resolution number 02 (2002), of National Education 
Council/Higher Education Council (CNE/CES), of 2002,complementary training on 
ambulatory care services is required. 
In addition to human resources, infrastructure is an important component to 
confer quality to healthcare services. In this study, the infrastructure that was used 
was in agreement with the national and international literature, which recommends 
the existence of a private or semiprivate space with appropriate furniture, able to 
promote the safe and efficient workflow of pharmacists, academics, patients, and/or 
caregivers while attended at the Medication Review service (Aguiar et al., 2013; 
França-Filho et al., 2008; Lyra Jr., 2005; Pharmaceutical Society of Australia, 
2011).In the practice of the Medication Review service, the existence of a private 
area for pharmaceutical care contributed to the creation of therapeutic relationships 
between pharmacists, Pharmacy students, and patients. To support this notion, the 
study of Pringle et al. (2011) demonstrated that the patient achieves good health 
outcomes when a therapeutic bond is formed with the pharmacist. However, França-
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Filho et al. (2008) found that only 11.4% of pharmacies providing pharmaceutical 
services in the State of Santa Catarina (Brazil) had a private or semiprivate area. 
In the Medication Review service that was studied, clinical pharmacy services 
was given in the same area where medical examinations were performed and 
immediately after they occurred to avoid further displacement to the hospital, 
especially for patients coming from other cities or states. Moreover, when problems 
are detected when reviewing a patient’s medication, pharmacists and Pharmacy 
students may intervene immediately with doctors to optimize the pharmacotherapy 
prescribed. However, in this service the therapeutic relationship was compromised as 
the consultations were short and did not allow detailed interviewing of patients.  
In Australia and Finland, Medication Review that starts in the community 
pharmacy or in the doctor's office may be complemented at home, thus facilitating 
the therapeutic pharmacist-patient relationship (Leikola, 2012; Pharmaceutical 
Society of Australia, 2011). It is important to emphasize some benefits of homecare, 
such as identification of discrepancies with medicines dispensed in community 
pharmacies, storage and administration of pharmacotherapy, and lifestyles that 
influence the use of medications (Hsia et al., 1997; Leikola, 2012; Yang et al., 2001). 
According to these authors, the patients’ home environment is more comfortable and 
suitable for the creation of a therapeutic relationship with the patient. In the future, 
the extension of Medication Review services to domiciliary care, integrated with other 
hospital clinical services such as Pharmacy residency, may represent an effective 
strategy to improve patient care. 
As for material resources, consultation of information sources about 
medications was not compromised in this study by the absence of computers 
connected to internet. In this study, updated textbooks, scientific papers, standards, 
and relevant legislation(laws, resolutions, ordinances, etc.), booklets, and materials 
developed by the authors were rendered available, in addition to mobile internet 
resources that were available by tablet, which enabled efficient database 
consultations as recommended by the literature (França-Filho et al., 2008; Wazaify et 
al., 2004; Zehnder et al., 2004). 
To provide this, pharmacists and Pharmacy students working in the service had 
unlimited access to medical sources of information, which required specific training 
and knowledge of other languages. Therefore, the results obtained were better than 
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those found in other national and international studies (Correr et al., 2004; Rodríguez 
et al., 2000). Although the literature suggests that clinical pharmacy services should 
have clinical devices (sphygmomanometer, glucometer, thermometer, etc.), they 
were not necessary in this study, since clinical and laboratory examinations were 
performed by physicians or clinical laboratories, and the results were rendered 
available to the entire staff in the records (Rios et al., 2013; Silva, 2003).Furthermore, 
documentation is a structural indicator for services. 
Zierler-Brown et al. (2007) state that documentation should be clear, concise, 
readable, free of judgments, systematized, centered on the patient, and ensure 
confidentiality. Therefore, the preparation of structured forms to document the care 
provided in this study, the training of the team in documentation and service 
simulation, combined with patients’ availability and their clinical information (medical 
records, clinical and laboratory examinations, and medical reports),led to 
pharmacists’ records meeting the literature recommendations. Moreover, Mackinnon 
and Mackinnon (2008) argue that documentation is necessary for the communication 
between pharmacists and other health care professionals, which stresses their 
importance in decision-making and patients’ clinical outcomes. Besides, the 
documentation used by the service should undergo continuous updates to satisfy 
new requirements presented by each patient.  
Regarding funding indicators, studies suggest that in other countries, health 
providers pay for patient care services and support clinical pharmacy services 
(Consejería de Sanidad y Consumo, 2006; Kuo et al., 2004; Leikola, 2012). Although 
the Medication Review service charges the consultation according to the Brazilian 
Unified Health System (SUS) Table in an innovative way, the resources obtained are 
not directly reverted to support the service. Moreover, service functioning depends on 
the fellowships of undergraduate and graduate students. Then, it is necessary to 
implement measures that aim to support the service, through the recruitment of 
pharmacists, investment in specific structures, and integration with other services, 
such as the residency. 
  
 
CONCLUSION 
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This study emphasized structural indicators required to evaluate the Medication 
Review service. Additionally, the developed structure satisfied the majority of the 
indicators proposed and may contribute to the establishment of structural standards 
for similar services. In a complementary form, it is expected that further studies 
should focus on work processes of Medication Review at ambulatory levels. It will 
thus be possible to implement structured Medication Review services with well-
defined workflows and positive results for patients and health professional teams. 
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RESEARCH HIGHLIGHTS 
 
 We gathered 28 structure indicators that were divided into five categories.  
 Categories: physical areas, documentation, funding, human resources and 
material.  
 Several international indicators found were similar to national indicators. 
 The Medication Review Service analyzed attended most indicators gathered. 
 This study may contribute to the establishment of structural standards. 
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HEALTH & PLACE 
 
Guide for authors 
 
 
INTRODUCTION 
 
The journal is an interdisciplinary journal dedicated to the study of all aspects 
of health and health care in which place or location matters. 
Recent years have seen closer links evolving between medical geography, 
medical sociology, health policy, public health and epidemiology. The journal reflects 
these convergences, which emphasise differences in health and health care between 
places, the experience of health and care in specific places, the development of 
health care for places, and the methodologies and theories underpinning the study of 
these issues. 
The journal brings together international contributors from geography, 
sociology, social policy and public health. It offers readers comparative perspectives 
on the difference that place makes to the incidence of ill-health, the structuring of 
health-related behaviour, the provision and use of health services, and the 
development of health policy. 
At a time when health matters are the subject of ever-
increasing attention, Health & Place provides accessible and readable papers 
summarizing developments and reporting the latest research findings. 
 
Types of paper  
 
Articles should normally be 4000-6000 words long, although articles longer 
than 6000 words will be accepted on an occasional basis, if the topic demands this 
length of treatment. Authors are responsible for ensuring that all manuscripts 
(whether original or revised) are accurately typed before final submission. 
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Manuscripts will be returned to the author with a set of instructions if they are not 
submitted according to our style. 
The Short Reports section allows authors to submit material which might not 
be appropriate for full-length articles but is worthy of publication. It may report work-
in-progress or elements of larger projects (1000-2000 words). 
The viewpoints section exists for the expression of opinion and as a forum for 
debate (1000-2000 words). 
Review papers may provide scholarly assessments of new policies or 
practices, or academic overviews of new areas of study (5000-6000 words). 
 
Special issue policy  
 
Our policy on special issues is that we will not do complete special issues, 
rather we will consider special sections of 4-10 papers. Specials need to be proposed 
to the Editor in Chief and will be evaluated by Assistant Editors and one 
or more Board Members and/or external advisors. Proposals should normally include 
abstracts and must include a clearly argued case for the special. Exceptionally we 
will consider specials based around a call-for-papers. Evaluation will focus on the 
coherence, topicality and market for the special. We expect specials to pursue an 
agenda and to be introduced by an agenda-setting paper, which could take the form 
of a guest editorial. All papers in specials, including the lead paper should be 
submitted in the normal way and will undergo normal peer review. We anticipate one 
special per year. 
 
Contact details for submission  
 
Health & Place has an online submission system with the aim of improving our 
editorial procedure for authors, reviewers and the editor. The website address 
is: http://ees.elsevier.com/jhap. 
If this is your first time using the system you will need to go to the above page 
and register as a new author by clicking the 'Register' link. Once registered you may 
then submit your paper by clicking 'Submit New Manuscript' and following the 
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instructions. All correspondence between the editor and authors will be performed by 
e-mail and paper copies will not be required at the original submission stage. 
 
Review Policy 
 
Please note that the journal has adopted a double blind reviewing policy, so 
authors should use separate pages for all identifying information (name, affiliation 
etc.). Replace all references to the author in the main paper with "Author, 2003", 
"Author et al, 2006", etc. In the reference list, use the format "Author 2003 [details 
removed for peer review]".Papers that have not had all such features removed 
will be returned without review to the author for alteration. Reviewer's names will 
not be made available to authors under any circumstances. 
 
BEFORE YOU BEGIN 
 
Ethics in publishing 
  
For information on Ethics in publishing and Ethical guidelines for journal 
publication see 
http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-
authors/ethics. 
 
Conflict of interest  
 
All authors are requested to disclose any actual or potential conflict of interest 
including any financial, personal or other relationships with other people or 
organizations within three years of beginning the submitted work that could 
inappropriately influence, or be perceived to influence, their work. See 
alsohttp://www.elsevier.com/conflictsofinterest. Further information and an example 
of a Conflict of Interest form can be found 
at: http://help.elsevier.com/app/answers/detail/a_id/286/p/7923. 
 
Submission declaration and verification 
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Submission of an article implies that the work described has not been published 
previously (except in the form of an abstract or as part of a published lecture or 
academic thesis or as an electronic preprint, 
seehttp://www.elsevier.com/postingpolicy), that it is not under consideration for 
publication elsewhere, that its publication is approved by all authors and tacitly or 
explicitly by the responsible authorities where the work was carried out, and that, if 
accepted, it will not be published elsewhere in the same form, in English or in any 
other language, including electronically without the written consent of the copyright-
holder. To verify originality, your article may be checked by the originality detection 
service CrossCheck http://www.elsevier.com/editors/plagdetect. 
 
Changes to authorship  
 
This policy concerns the addition, deletion, or rearrangement of author names 
in the authorship of accepted manuscripts: 
 
Before the accepted manuscript is published in an online issue: Requests to 
add or remove an author, or to rearrange the author names, must be sent to the 
Journal Manager from the corresponding author of the accepted manuscript and 
must include: (a) the reason the name should be added or removed, or the author 
names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors 
that they agree with the addition, removal or rearrangement. In the case of addition 
or removal of authors, this includes confirmation from the author being added or 
removed. Requests that are not sent by the corresponding author will be forwarded 
by the Journal Manager to the corresponding author, who must follow the procedure 
as described above. Note that: (1) Journal Managers will inform the Journal Editors 
of any such requests and (2) publication of the accepted manuscript in an online 
issue is suspended until authorship has been agreed. 
 
After the accepted manuscript is published in an online issue: Any requests to 
add, delete, or rearrange author names in an article published in an online issue will 
follow the same policies as noted above and result in a corrigendum. 
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Copyright  
 
This journal offers authors a choice in publishing their research: Open 
access and Subscription. 
 
For subscription articles 
 
Upon acceptance of an article, authors will be asked to complete a 'Journal 
Publishing Agreement' (for more information on this and copyright, 
see http://www.elsevier.com/copyright). An e-mail will be sent to the corresponding 
author confirming receipt of the manuscript together with a 'Journal Publishing 
Agreement' form or a link to the online version of this agreement. 
Subscribers may reproduce tables of contents or prepare lists of articles including 
abstracts for internal circulation within their institutions. Permission of the Publisher is 
required for resale or distribution outside the institution and for all other derivative 
works, including compilations and translations (please 
consulthttp://www.elsevier.com/permissions). If excerpts from other copyrighted 
works are included, the author(s) must obtain written permission from the copyright 
owners and credit the source(s) in the article. Elsevier has preprinted forms for use 
by authors in these cases: please consult http://www.elsevier.com/permissions. 
 
For open access articles 
 
Upon acceptance of an article, authors will be asked to complete an 'Exclusive 
License Agreement' (for more information 
see http://www.elsevier.com/OAauthoragreement). Permitted reuse of open access 
articles is determined by the author's choice of user license 
(see http://www.elsevier.com/openaccesslicenses). 
 
Retained author rights 
 
As an author you (or your employer or institution) retain certain rights. For 
more information on author rights for: 
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Subscription articles please see http://www.elsevier.com/journal-authors/author-
rights-and-responsibilities. 
Open access articles please see http://www.elsevier.com/OAauthoragreement. 
 
Role of the funding source 
 
You are requested to identify who provided financial support for the conduct of 
the research and/or preparation of the article and to briefly describe the role of the 
sponsor(s), if any, in study design; in the collection, analysis and interpretation of 
data; in the writing of the report; and in the decision to submit the article for 
publication. If the funding source(s) had no such involvement then this should be 
stated. 
 
Funding body agreements and policies  
 
Elsevier has established agreements and developed policies to allow authors 
whose articles appear in journals published by Elsevier, to comply with potential 
manuscript archiving requirements as specified as conditions of their grant awards. 
To learn more about existing agreements and policies please 
visithttp://www.elsevier.com/fundingbodies. 
 
Open access 
 
This journal offers authors a choice in publishing their research: 
 
Open access 
 
• Articles are freely available to both subscribers and the wider public with 
permitted reuse 
• An open access publication fee is payable by authors or their research 
funder  
 
Subscription 
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• Articles are made available to subscribers as well as developing countries 
and patient groups through our access programs (http://www.elsevier.com/access) 
• No open access publication fee 
 
All articles published open access will be immediately and permanently free 
for everyone to read and download. Permitted reuse is defined by your choice of one 
of the following Creative Commons user licenses: 
Creative Commons Attribution (CC BY): lets others distribute and copy the 
article, to create extracts, abstracts, and other revised versions, adaptations or 
derivative works of or from an article (such as a translation), to include in a collective 
work (such as an anthology), to text or data mine the article, even for commercial 
purposes, as long as they credit the author(s), do not represent the author as 
endorsing their adaptation of the article, and do not modify the article in such a way 
as to damage the author's honor or reputation. 
Creative Commons Attribution-NonCommercial-ShareAlike (CC BY-NC-
SA): for non-commercial purposes, lets others distribute and copy the article, to 
create extracts, abstracts and other revised versions, adaptations or derivative works 
of or from an article (such as a translation), to include in a collective work (such as an 
anthology), to text and data mine the article, as long as they credit the author(s), do 
not represent the author as endorsing their adaptation of the article, do not modify 
the article in such a way as to damage the author's honor or reputation, and license 
their new adaptations or creations under identical terms (CC BY-NC-SA). 
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-
ND): for non-commercial purposes, lets others distribute and copy the article, and to 
include in a collective work (such as an anthology), as long as they credit the 
author(s) and provided they do not alter or modify the article. 
To provide open access, this journal has a publication fee which needs to be 
met by the authors or their research funders for each article published open access.  
Your publication choice will have no effect on the peer review process or acceptance 
of submitted articles. 
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The open access publication fee for this journal is $1800, excluding taxes. 
Learn more about Elsevier's pricing 
policy: http://www.elsevier.com/openaccesspricing. 
 
Language (usage and editing services)  
 
Please write your text in good English (American or British usage is accepted, 
but not a mixture of these). Authors who feel their English language manuscript may 
require editing to eliminate possible grammatical or spelling errors and to conform to 
correct scientific English may wish to use the English Language Editing service 
available from Elsevier's WebShop (http://webshop.elsevier.com/languageediting/) or 
visit our customer support site (http://support.elsevier.com) for more information. 
 
PREPARATION 
 
NEW SUBMISSIONS  
 
Submission to this journal proceeds totally online and you will be guided 
stepwise through the creation and uploading of your files. The system automatically 
converts your files to a single PDF file, which is used in the peer-review process. 
As part of the Your Paper Your Way service, you may choose to submit your 
manuscript as a single file to be used in the refereeing process. This can be a PDF 
file or a Word document, in any format or lay-out that can be used by referees to 
evaluate your manuscript. It should contain high enough quality figures for refereeing. 
If you prefer to do so, you may still provide all or some of the source files at the initial 
submission. Please note that individual figure files larger than 10 MB must be 
uploaded separately. 
 
References  
 
There are no strict requirements on reference formatting at submission. 
References can be in any style or format as long as the style is consistent. Where 
applicable, author(s) name(s), journal title/book title, chapter title/article title, year of 
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publication, volume number/book chapter and the pagination must be present. Use of 
DOI is highly encouraged. The reference style used by the journal will be applied to 
the accepted article by Elsevier at the proof stage. Note that missing data will be 
highlighted at proof stage for the author to correct. 
 
Formatting requirements 
 
There are no strict formatting requirements but all manuscripts must contain 
the essential elements needed to convey your manuscript, for example Abstract, 
Keywords, Introduction, Materials and Methods, Results, Conclusions, Artwork and 
Tables with Captions. 
If your article includes any Videos and/or other Supplementary material, this 
should be included in your initial submission for peer review purposes. 
Divide the article into clearly defined sections. 
 
Figures and tables embedded in text  
 
Please ensure the figures and the tables included in the single file are placed 
next to the relevant text in the manuscript, rather than at the bottom or the top of the 
file. 
 
REVISED SUBMISSIONS 
 
Use of word processing software  
 
Regardless of the file format of the original submission, at revision you must 
provide us with an editable file of the entire article. Keep the layout of the text as 
simple as possible. Most formatting codes will be removed and replaced on 
processing the article. The electronic text should be prepared in a way very similar to 
that of conventional manuscripts (see also the Guide to Publishing with 
Elsevier: http://www.elsevier.com/guidepublication). See also the section on 
Electronic artwork.  
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To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 
'grammar-check' functions of your word processor. 
 
Article structure 
 
Essential title page information 
 
• Title. Concise and informative. Titles are often used in information-retrieval 
systems. Avoid abbreviations and formulae where possible. 
• Author names and affiliations. Where the family name may be ambiguous 
(e.g., a double name), please indicate this clearly. Present the authors' affiliation 
addresses (where the actual work was done) below the names. Indicate all affiliations 
with a lower-case superscript letter immediately after the author's name and in front 
of the appropriate address. Provide the full postal address of each affiliation, 
including the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at 
all stages of refereeing and publication, also post-publication. Ensure that phone 
numbers (with country and area code) are provided in addition to the e-mail 
address and the complete postal address. Contact details must be kept up to 
date by the corresponding author. 
• Present/permanent address. If an author has moved since the work 
described in the article was done, or was visiting at the time, a 'Present address' (or 
'Permanent address') may be indicated as a footnote to that author's name. The 
address at which the author actually did the work must be retained as the main, 
affiliation address. Superscript Arabic numerals are used for such footnotes. 
 
Optimizing the title and abstract of an article for your audience 
 
In order to increase the exposure of your article, we suggest the following: 
•The title of your article must be clear and descriptive, using keywords that are 
relevant to the subject area, and would most likely be used in an online search. 
•The abstract must also contain keywords and common phrases for the 
subject area, perhaps using wording from the title. These carefully chosen keywords 
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and phrases can also be emphasised in the text, however please do this with caution 
as some search engines can reject overly repetitive webpages. 
 
Abstract  
 
A concise and factual abstract of about 100 words is required. The abstract 
should state briefly the purpose of the research, the principal results and major 
conclusions. An abstract is often presented separately from the article, so it must be 
able to stand alone. For this reason, References should be avoided, but if essential, 
then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations 
should be avoided, but if essential they must be defined at their first mention in the 
abstract itself. 
 
Highlights  
 
Highlights are mandatory for this journal. They consist of a short collection of 
bullet points that convey the core findings of the article and should be submitted in a 
separate editable file in the online submission system. Please use 'Highlights' in the 
file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, 
per bullet point). See http://www.elsevier.com/highlights for examples. 
 
Keywords  
 
Immediately after the abstract, provide a maximum of 6 keywords, using 
American spelling and avoiding general and plural terms and multiple concepts 
(avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations 
firmly established in the field may be eligible. These keywords will be used for 
indexing purposes. 
 
Footnotes  
 
Footnotes should be used sparingly. Number them consecutively throughout 
the article. Many word processors build footnotes into the text, and this feature may 
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be used. Should this not be the case, indicate the position of footnotes in the text and 
present the footnotes themselves separately at the end of the article. Do not include 
footnotes in the Reference list. 
 
 
Artwork 
 
Electronic artwork  
 
General points 
• Make sure you use uniform lettering and sizing of your original artwork. 
• Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, 
Courier. 
• Number the illustrations according to their sequence in the text. 
• Use a logical naming convention for your artwork files. 
• Indicate per figure if it is a single, 1.5 or 2-column fitting image. 
• For Word submissions only, you may still provide figures and their captions, 
and tables within a single file at the revision stage. 
• Please note that individual figure files larger than 10 MB must be provided in 
separate source files. 
A detailed guide on electronic artwork is available on our website:  
http://www.elsevier.com/artworkinstructions.  
You are urged to visit this site; some excerpts from the detailed 
information are given here.  
 
Formats  
 
Regardless of the application used, when your electronic artwork is finalized, 
please 'save as' or convert the images to one of the following formats (note the 
resolution requirements for line drawings, halftones, and line/halftone combinations 
given below): 
EPS (or PDF): Vector drawings. Embed the font or save the text as 'graphics'. 
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TIFF (or JPG): Color or grayscale photographs (halftones): always use a 
minimum of 300 dpi. 
TIFF (or JPG): Bitmapped line drawings: use a minimum of 1000 dpi. 
TIFF (or JPG): Combinations bitmapped line/half-tone (color or grayscale): a 
minimum of 500 dpi is required.  
 
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); 
the resolution is too low. 
• Supply files that are too low in resolution. 
• Submit graphics that are disproportionately large for the content. 
 
Color artwork  
 
Please make sure that artwork files are in an acceptable format (TIFF (or 
JPEG), EPS (or PDF), or MS Office files) and with the correct resolution. If, together 
with your accepted article, you submit usable color figures then Elsevier will ensure, 
at no additional charge, that these figures will appear in color on the Web (e.g., 
ScienceDirect and other sites) regardless of whether or not these illustrations are 
reproduced in color in the printed version. For color reproduction in print, you will 
receive information regarding the costs from Elsevier after receipt of your 
accepted article. Please indicate your preference for color: in print or on the Web 
only. For further information on the preparation of electronic artwork, please 
see http://www.elsevier.com/artworkinstructions.  
Please note: Because of technical complications that can arise by converting 
color figures to 'gray scale' (for the printed version should you not opt for color in 
print) please submit in addition usable black and white versions of all the color 
illustrations. 
 
Figure captions 
 
Ensure that each illustration has a caption. A caption should comprise a brief 
title (not on the figure itself) and a description of the illustration. Keep text in the 
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illustrations themselves to a minimum but explain all symbols and abbreviations 
used. 
 
Tables  
 
Number tables consecutively in accordance with their appearance in the text. 
Place footnotes to tables below the table body and indicate them with superscript 
lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that 
the data presented in tables do not duplicate results described elsewhere in the 
article. 
 
References 
 
Citation in text  
 
Please ensure that every reference cited in the text is also present in the 
reference list (and vice versa). Any references cited in the abstract must be given in 
full. Unpublished results and personal communications are not recommended in the 
reference list, but may be mentioned in the text. If these references are included in 
the reference list they should follow the standard reference style of the journal and 
should include a substitution of the publication date with either 'Unpublished results' 
or 'Personal communication'. Citation of a reference as 'in press' implies that the item 
has been accepted for publication. 
 
Reference links  
 
Increased discoverability of research and high quality peer review are ensured 
by online links to the sources cited. In order to allow us to create links to abstracting 
and indexing services, such as Scopus, CrossRef and PubMed, please ensure that 
data provided in the references are correct. Please note that incorrect surnames, 
journal/book titles, publication year and pagination may prevent link creation. When 
copying references, please be careful as they may already contain errors. Use of the 
DOI is encouraged. 
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Web references  
 
As a minimum, the full URL should be given and the date when the reference 
was last accessed. Any further information, if known (DOI, author names, dates, 
reference to a source publication, etc.), should also be given. Web references can be 
listed separately (e.g., after the reference list) under a different heading if desired, or 
can be included in the reference list. 
 
References in a special issue 
 
Please ensure that the words 'this issue' are added to any references in the list 
(and any citations in the text) to other articles in the same Special Issue. 
 
Reference management software 
 
This journal has standard templates available in key reference management 
packages EndNote (http://www.endnote.com/support/enstyles.asp) and Reference 
Manager (http://refman.com/support/rmstyles.asp). Using plug-ins to word processing 
packages, authors only need to select the appropriate journal template when 
preparing their article and the list of references and citations to these will be 
formatted according to the journal style which is described below. 
 
Reference formatting  
 
There are no strict requirements on reference formatting at submission. 
References can be in any style or format as long as the style is consistent. Where 
applicable, author(s) name(s), journal title/book title, chapter title/article title, year of 
publication, volume number/book chapter and the pagination must be present. Use of 
DOI is highly encouraged. The reference style used by the journal will be applied to 
the accepted article by Elsevier at the proof stage. Note that missing data will be 
highlighted at proof stage for the author to correct. If you do wish to format the 
references yourself they should be arranged according to the following examples: 
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Reference Style  
 
For Health & Place the Harvard system is to be used: authors' names (no 
initials) and dates (and specific pages, only in the case of quotations) are given in the 
main body of the text, e.g. (Phillips, 1990, p, 40). References are listed alphabetically 
at the end of the paper, double spaced and conform to current journal style: 
For journals: Macintyre, S., Maclver, S., Sooman, A., 1993. Area, class and 
health: should we be focusing on places or people? Journal of Social Policy 22, 213-
234. 
For books: Jones, K., Moon, G., 1987. Health, Disease and Society. RKP, 
London. 
For Chapters of edited Books: Laws, G., Dear, M., 1988. Coping in the 
community: a review of factors and influencing the lives of deinstitutionalized ex-
psychiatric patients. In: Smith, C., Giggs, J. (Eds), Location and Stigma. Unwin 
Hyman, London, pp. 83-102. 
Other publications: Where there is doubt include bibliographical details. 
 
Video data  
 
Elsevier accepts video material and animation sequences to support and 
enhance your scientific research. Authors who have video or animation files that they 
wish to submit with their article are strongly encouraged to include links to these 
within the body of the article. This can be done in the same way as a figure or table 
by referring to the video or animation content and noting in the body text where it 
should be placed. All submitted files should be properly labeled so that they directly 
relate to the video file's content. In order to ensure that your video or animation 
material is directly usable, please provide the files in one of our recommended file 
formats with a preferred maximum size of 50 MB. Video and animation files supplied 
will be published online in the electronic version of your article in Elsevier Web 
products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' 
with your files: you can choose any frame from the video or animation or make a 
separate image. These will be used instead of standard icons and will personalize 
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the link to your video data. For more detailed instructions please visit our video 
instruction pages at http://www.elsevier.com/artworkinstructions. Note: since video 
and animation cannot be embedded in the print version of the journal, please provide 
text for both the electronic and the print version for the portions of the article that 
refer to this content. 
 
AudioSlides  
 
The journal encourages authors to create an AudioSlides presentation with 
their published article. AudioSlides are brief, webinar-style presentations that are 
shown next to the online article on ScienceDirect. This gives authors the opportunity 
to summarize their research in their own words and to help readers understand what 
the paper is about. More information and examples are available 
at http://www.elsevier.com/audioslides. Authors of this journal will automatically 
receive an invitation e-mail to create an AudioSlides presentation after acceptance of 
their paper. 
 
Supplementary data  
 
Elsevier accepts electronic supplementary material to support and enhance 
your scientific research. Supplementary files offer the author additional possibilities to 
publish supporting applications, high-resolution images, background datasets, sound 
clips and more. Supplementary files supplied will be published online alongside the 
electronic version of your article in Elsevier Web products, including 
ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted 
material is directly usable, please provide the data in one of our recommended file 
formats. Authors should submit the material in electronic format together with the 
article and supply a concise and descriptive caption for each file. For more detailed 
instructions please visit our artwork instruction pages 
athttp://www.elsevier.com/artworkinstructions. 
 
Google Maps and KML files  
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KML (Keyhole Markup Language) files (optional): You can enrich your online 
articles by providing KML or KMZ files which will be visualized using Google maps. 
The KML or KMZ files can be uploaded in our online submission system. KML is an 
XML schema for expressing geographic annotation and visualization within Internet-
based Earth browsers. Elsevier will generate Google Maps from the submitted KML 
files and include these in the article when published online. Submitted KML files will 
also be available for downloading from your online article on ScienceDirect. For more 
information see http://www.elsevier.com/googlemaps. 
 
Checklist  
 
 
•Have you told readers, at the outset, what they might gain by reading your 
paper? 
•Have you made the aim of your work clear? 
•Have you explained the significance of your contribution? 
•Have you set your work in the appropriate context by giving sufficient 
background (including a complete set of relevant references) to your work? 
•Have you addressed the question of practicality and usefulness? 
•Have you identified future developments that may result from you work? 
•Have you structured you papers in a clear and logical fashion? 
•Have you provided an abstract and keywords? 
 
Submission checklist  
 
The following list will be useful during the final checking of an article prior to 
sending it to the journal for review. Please consult this Guide for Authors for further 
details of any item. 
  
Ensure that the following items are present:  
 
One author has been designated as the corresponding author with contact 
details:  
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• E-mail address  
• Full postal address  
• Telephone  
All necessary files have been uploaded, and contain:  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spell-checked' and 'grammar-checked'  
• All references mentioned in the Reference list are cited in the text, and vice 
versa 
• Permission has been obtained for use of copyrighted material from other 
sources (including the Web)  
• Color figures are clearly marked as being intended for color reproduction on 
the Web (free of charge) and in print, or to be reproduced in color on the Web (free of 
charge) and in black-and-white in print  
• If only color on the Web is required, black-and-white versions of the figures 
are also supplied for printing purposes  
 
For any further information please visit our customer support site 
at http://support.elsevier.com. 
 
AFTER ACCEPTANCE 
 
Use of the Digital Object Identifier  
 
The Digital Object Identifier (DOI) may be used to cite and link to electronic 
documents. The DOI consists of a unique alpha-numeric character string which is 
assigned to a document by the publisher upon the initial electronic publication. The 
assigned DOI never changes. Therefore, it is an ideal medium for citing a document, 
particularly 'Articles in press' because they have not yet received their full 
bibliographic information. Example of a correctly given DOI (in URL format; here an 
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article in the journal Physics Letters B):  
http://dx.doi.org/10.1016/j.physletb.2010.09.059.  
When you use a DOI to create links to documents on the web, the DOIs are 
guaranteed never to change. 
 
Online proof correction  
 
Corresponding authors will receive an e-mail with a link to our online proofing 
system, allowing annotation and correction of proofs online. The environment is 
similar to MS Word: in addition to editing text, you can also comment on 
figures/tables and answer questions from the Copy Editor. Web-based proofing 
provides a faster and less error-prone process by allowing you to directly type your 
corrections, eliminating the potential introduction of errors. 
If preferred, you can still choose to annotate and upload your edits on the PDF 
version. All instructions for proofing will be given in the e-mail we send to authors, 
including alternative methods to the online version and PDF. 
We will do everything possible to get your article published quickly and 
accurately. Please use this proof only for checking the typesetting, editing, 
completeness and correctness of the text, tables and figures. Significant changes to 
the article as accepted for publication will only be considered at this stage with 
permission from the Editor. It is important to ensure that all corrections are sent back 
to us in one communication. Please check carefully before replying, as inclusion of 
any subsequent corrections cannot be guaranteed. Proofreading is solely your 
responsibility. 
 
Offprints  
 
The corresponding author, at no cost, will be provided with a PDF file of the 
article via e-mail (the PDF file is a watermarked version of the published article and 
includes a cover sheet with the journal cover image and a disclaimer outlining the 
terms and conditions of use). For an extra charge, paper offprints can be ordered via 
the offprint order form which is sent once the article is accepted for publication. Both 
corresponding and co-authors may order offprints at any time via Elsevier's 
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WebShop (http://webshop.elsevier.com/myarticleservices/offprints). Authors requiring 
printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own 
Book' service to collate multiple articles within a single cover 
(http://webshop.elsevier.com/myarticleservices/booklets). 
  
 
AUTHOR INQUIRIES 
 
You can track your submitted article 
at http://help.elsevier.com/app/answers/detail/a_id/89/p/8045/. You can track your 
accepted article at http://www.elsevier.com/trackarticle. You are also welcome to 
contact Customer Support viahttp://support.elsevier.com. 
 
